Certara (NASDAQ:CERT) Trading Down 4.3%

Certara, Inc. (NASDAQ:CERT) traded down 4.3% during trading on Tuesday . The stock traded as low as $13.75 and last traded at $13.75. 794,592 shares changed hands during mid-day trading, an increase of 46% from the average session volume of 543,688 shares. The stock had previously closed at $14.37.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Leerink Partnrs reaffirmed a “market perform” rating on shares of Certara in a research note on Monday, February 26th. KeyCorp raised Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 price objective on the stock in a research note on Wednesday, April 10th. UBS Group raised their price objective on Certara from $17.00 to $20.00 and gave the stock a “neutral” rating in a research note on Friday, March 1st. Jefferies Financial Group lifted their target price on Certara from $14.00 to $15.50 and gave the company a “hold” rating in a research note on Friday, March 1st. Finally, JMP Securities started coverage on Certara in a research note on Thursday, April 4th. They set a “market perform” rating on the stock. Seven investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $20.06.

Certara Price Performance

The firm has a market cap of $2.15 billion, a PE ratio of -34.28, a PEG ratio of 5.00 and a beta of 1.58. The firm has a fifty day simple moving average of $16.72 and a two-hundred day simple moving average of $17.02. The company has a debt-to-equity ratio of 0.27, a quick ratio of 3.26 and a current ratio of 3.26.

Certara (NASDAQ:CERT) last announced its earnings results on Tuesday, May 7th. The company reported $0.06 EPS for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.01). The company had revenue of $96.65 million during the quarter, compared to analysts’ expectations of $94.48 million. Certara had a positive return on equity of 4.08% and a negative net margin of 17.02%. Equities analysts predict that Certara, Inc. will post 0.29 EPS for the current fiscal year.

Insider Activity at Certara

In related news, SVP Richard M. Traynor sold 3,000 shares of the business’s stock in a transaction on Monday, April 1st. The stock was sold at an average price of $18.00, for a total transaction of $54,000.00. Following the completion of the transaction, the senior vice president now owns 173,524 shares in the company, valued at approximately $3,123,432. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Certara news, insider Patrick F. Smith sold 14,427 shares of Certara stock in a transaction on Tuesday, April 2nd. The stock was sold at an average price of $16.85, for a total transaction of $243,094.95. Following the completion of the sale, the insider now directly owns 50,091 shares of the company’s stock, valued at approximately $844,033.35. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Richard M. Traynor sold 3,000 shares of Certara stock in a transaction on Monday, April 1st. The shares were sold at an average price of $18.00, for a total value of $54,000.00. Following the sale, the senior vice president now directly owns 173,524 shares of the company’s stock, valued at $3,123,432. The disclosure for this sale can be found here. 2.39% of the stock is owned by company insiders.

Institutional Investors Weigh In On Certara

A number of institutional investors and hedge funds have recently bought and sold shares of CERT. Mubadala Investment Co PJSC bought a new stake in Certara during the 4th quarter valued at $169,135,000. Wasatch Advisors LP raised its position in shares of Certara by 23.4% in the 1st quarter. Wasatch Advisors LP now owns 4,924,845 shares of the company’s stock worth $88,056,000 after acquiring an additional 932,598 shares in the last quarter. Geneva Capital Management LLC raised its position in shares of Certara by 29.0% in the 4th quarter. Geneva Capital Management LLC now owns 3,824,850 shares of the company’s stock worth $67,279,000 after acquiring an additional 860,763 shares in the last quarter. Norges Bank bought a new position in shares of Certara in the 4th quarter worth $14,262,000. Finally, Rathbones Group PLC bought a new position in shares of Certara in the 3rd quarter worth $11,007,000. 73.96% of the stock is owned by institutional investors.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.